Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$11.01
-0.640 (-5.49%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $10.48 $12.11 Thursday, 9th May 2024 DVAX stock ended at $11.01. This is 5.49% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 6.49% from a day low at $10.48 to a day high of $11.16.
90 days $10.48 $13.27
52 weeks $10.48 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Jan 24, 2023 $11.50 $11.72 $11.49 $11.68 889 658
Jan 23, 2023 $11.35 $11.59 $11.30 $11.58 1 110 300
Jan 20, 2023 $11.31 $11.35 $11.06 $11.30 1 946 189
Jan 19, 2023 $11.13 $11.30 $11.04 $11.15 918 641
Jan 18, 2023 $11.35 $11.68 $11.16 $11.17 1 214 100
Jan 17, 2023 $11.30 $11.37 $11.13 $11.35 1 145 574
Jan 13, 2023 $11.13 $11.57 $11.06 $11.35 1 198 282
Jan 12, 2023 $10.97 $11.44 $10.77 $11.42 1 526 230
Jan 11, 2023 $10.64 $11.06 $10.49 $10.96 1 544 546
Jan 10, 2023 $10.31 $10.74 $10.26 $10.68 1 326 347
Jan 09, 2023 $10.62 $10.62 $9.98 $10.27 1 871 300
Jan 06, 2023 $10.43 $10.63 $10.27 $10.54 1 265 400
Jan 05, 2023 $10.50 $10.58 $10.37 $10.37 1 000 659
Jan 04, 2023 $10.65 $10.76 $10.53 $10.57 1 145 085
Jan 03, 2023 $10.75 $10.92 $10.56 $10.60 1 063 756
Dec 30, 2022 $10.52 $10.65 $10.39 $10.64 1 124 782
Dec 29, 2022 $10.39 $10.81 $10.28 $10.66 1 408 490
Dec 28, 2022 $10.29 $10.48 $10.21 $10.27 1 143 981
Dec 27, 2022 $10.78 $10.80 $10.30 $10.31 1 207 364
Dec 23, 2022 $11.40 $11.42 $10.77 $10.79 1 190 591
Dec 22, 2022 $11.26 $11.46 $11.00 $11.42 2 415 618
Dec 21, 2022 $11.29 $11.47 $11.18 $11.41 1 094 644
Dec 20, 2022 $10.78 $11.38 $10.78 $11.18 1 345 400
Dec 19, 2022 $11.25 $11.33 $10.80 $10.93 1 649 208
Dec 16, 2022 $10.81 $11.22 $10.78 $11.17 4 037 074
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT